| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |